Keck School Faculty

Fariba Navid

Fariba Navid

Professor of Clinical Pediatrics
CHL 4650 Sunset Blvd Off Campus Los Angeles

The Role of Pharmacotherapeutic Agents in Children with Desmoid Tumors Paediatr Drugs. 2022 Sep; 24(5):433-445. . View in PubMed

Primary Adrenal Malignant Rhabdoid Tumor in a 14-Year-Old Female: A Case Report and Literature Review Int J Surg Pathol. 2022 Apr; 30(2):172-176. . View in PubMed

Kaposiform hemangioendothelioma of the bone in children and adolescents Pediatr Blood Cancer. 2022 01; 69(1):e29392. . View in PubMed

Improved Outcome in Children With Newly Diagnosed High-Risk Neuroblastoma Treated With Chemoimmunotherapy: Updated Results of a Phase II Study Using hu1418K322A. J Clin Oncol. 2022 02 01; 40(4):335-344. . View in PubMed

A multidisciplinary approach to management of abdominal lymphatic malformations J Pediatr Surg. 2021 Aug; 56(8):1425-1429. . View in PubMed

Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force Pediatr Blood Cancer. 2021 09; 68(9):e29188. . View in PubMed

Rationale for the use of tyrosine kinase inhibitors in the treatment of paediatric desmoid-type fibromatosis Br J Cancer. 2021 05; 124(10):1637-1646. . View in PubMed

Custom Pediatric Oncology Next-Generation Sequencing Panel Identifies Somatic Mosaicism in Archival Tissue and Enhances Targeted Clinical Care Pediatr Neurol. 2021 01; 114:55-59. . View in PubMed

Phase I expansion cohort to evaluate the combination of bevacizumab, sorafenib and low-dose cyclophosphamide in children and young adults with refractory or recurrent solid tumours Eur J Cancer. 2020 06; 132:35-42. . View in PubMed

Pre-existing antitherapeutic antibodies against the Fc region of the hu1418K322A mAb are associated with outcome in patients with relapsed neuroblastoma. J Immunother Cancer. 2020 03; 8(1). . View in PubMed

A Phase 1 and pharmacokinetic study evaluating daily or weekly schedules of the humanized anti-GD2 antibody hu1418K322A in recurrent/refractory solid tumors. MAbs. 2020 Jan-Dec; 12(1):1773751. . View in PubMed

Embryonal rhabdomyosarcoma in a patient with a germline CBL pathogenic variant Cancer Genet. 2019 02; 231-232:62-66. . View in PubMed

Integrated analysis of long-term growth and bone development in pediatric and adolescent patients receiving bevacizumab Pediatr Blood Cancer. 2019 02; 66(2):e27487. . View in PubMed

A Phase II Trial of Hu1418K322A in Combination with Induction Chemotherapy in Children with Newly Diagnosed High-Risk Neuroblastoma. Clin Cancer Res. 2019 11 01; 25(21):6320-6328. . View in PubMed

Sorafenib Population Pharmacokinetics and Skin Toxicities in Children and Adolescents with Refractory/Relapsed Leukemia or Solid Tumor Malignancies Clin Cancer Res. 2019 12 15; 25(24):7320-7330. . View in PubMed

The role of routine imaging in pediatric cutaneous melanoma Pediatr Blood Cancer. 2018 12; 65(12):e27412. . View in PubMed

Health-Related Quality of Life and Survival Outcomes of Pediatric Patients With Nonmetastatic Osteosarcoma Treated in Countries With Different Resources J Glob Oncol. 2018 09; 4:1-11. . View in PubMed

Prognostic Value of Metabolic and Volumetric Parameters of FDG PET in Pediatric Osteosarcoma: A Hypothesis-generating Study Radiology. 2018 04; 287(1):303-312. . View in PubMed

18F-FDG Uptake During Early Adjuvant Chemotherapy Predicts Histologic Response in Pediatric and Young Adult Patients with Osteosarcoma J Nucl Med. 2018 01; 59(1):25-30. . View in PubMed

Multi-level otsu method to define metabolic tumor volume in positron emission tomography Am J Nucl Med Mol Imaging. 2018; 8(6):373-386. . View in PubMed

Prospective study of neuropathic pain after definitive surgery for extremity osteosarcoma in a pediatric population Pediatr Blood Cancer. 2017 03; 64(3). . View in PubMed

A phase II trial evaluating the feasibility of adding bevacizumab to standard osteosarcoma therapy Int J Cancer. 2017 10 01; 141(7):1469-1477. . View in PubMed

Use of Quantitative Dynamic Contrast-Enhanced Ultrasound to Assess Response to Antiangiogenic Therapy in Children and Adolescents With Solid Malignancies: A Pilot Study AJR Am J Roentgenol. 2016 May; 206(5):933-9. . View in PubMed

Pulmonary Function after Treatment for Childhood CancerA Report from the St. Jude Lifetime Cohort Study (SJLIFE). Ann Am Thorac Soc. 2016 09; 13(9):1575-85. . View in PubMed

Comparison of (18) F-FDG-PET-CT and Bone Scintigraphy for Evaluation of Osseous Metastases in Newly Diagnosed and Recurrent Osteosarcoma Pediatr Blood Cancer. 2016 08; 63(8):1381-6. . View in PubMed

Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma Pediatr Blood Cancer. 2016 07; 63(7):1207-13. . View in PubMed

Bevacizumab dosing strategy in paediatric cancer patients based on population pharmacokinetic analysis with external validation Br J Clin Pharmacol. 2016 Jan; 81(1):148-60. . View in PubMed

Limited Margin Radiation Therapy for Children and Young Adults With Ewing Sarcoma Achieves High Rates of Local Tumor Control Int J Radiat Oncol Biol Phys. 2016 09 01; 96(1):119-26. . View in PubMed

Pediatric Melanoma and Atypical Melanocytic Neoplasms Cancer Treat Res. 2016; 167:331-69. . View in PubMed

In Situ Tumor Vaccination by Combining Local Radiation and Tumor-Specific Antibody or Immunocytokine Treatments Cancer Res. 2016 07 01; 76(13):3929-41. . View in PubMed

Assessing vascular effects of adding bevacizumab to neoadjuvant chemotherapy in osteosarcoma using DCE-MRI Br J Cancer. 2015 Nov 03; 113(9):1282-8. . View in PubMed

Pneumothorax as a complication of combination antiangiogenic therapy in children and young adults with refractory/recurrent solid tumors J Pediatr Surg. 2015 Sep; 50(9):1484-9. . View in PubMed

Comparable efficacy with varying dosages of glucarpidase in pediatric oncology patients Pediatr Blood Cancer. 2015 Sep; 62(9):1518-22. . View in PubMed

FDG PET/CT imaging of desmoplastic small round cell tumor: findings at staging, during treatment and at follow-up Pediatr Radiol. 2015 Aug; 45(9):1308-15. . View in PubMed

Ocular abnormalities in patients treated with a novel anti-GD2 monoclonal antibody, hu1418K322A. J AAPOS. 2015 Apr; 19(2):112-5. . View in PubMed

Vincristine and Dactinomycin in Infantile Myofibromatosis With a Review of Treatment Options J Pediatr Hematol Oncol. 2015 Apr; 37(3):237-41. . View in PubMed

The genomic landscape of childhood and adolescent melanoma J Invest Dermatol. 2015 Mar; 135(3):816-823. . View in PubMed

Comparison of pain outcomes between two anti-GD2 antibodies in patients with neuroblastoma Pediatr Blood Cancer. 2015 02; 62(2):224-228. . View in PubMed

Influence of bony resection margins and surgicopathological factors on outcomes in limb-sparing surgery for extremity osteosarcoma Pediatr Blood Cancer. 2015 02; 62(2):246-251. . View in PubMed

An approach to renal masses in pediatrics Pediatrics. 2015 Jan; 135(1):142-58. . View in PubMed

Long-term pulmonary function after metastasectomy for childhood osteosarcoma: a report from the St Jude lifetime cohort study J Am Coll Surg. 2014 Aug; 219(2):265-71. . View in PubMed

Management of local recurrence of pediatric osteosarcoma following limb-sparing surgery Ann Surg Oncol. 2014 Jun; 21(6):1948-55. . View in PubMed

Population pharmacokinetics of bevacizumab in children with osteosarcoma: implications for dosing Clin Cancer Res. 2014 May 15; 20(10):2783-92. . View in PubMed

Phase I trial of a novel anti-GD2 monoclonal antibody, Hu1418K322A, designed to decrease toxicity in children with refractory or recurrent neuroblastoma. J Clin Oncol. 2014 May 10; 32(14):1445-52. . View in PubMed

Safety of ultrasound contrast agents in the pediatric oncologic population: a single-institution experience AJR Am J Roentgenol. 2014 May; 202(5):966-70. . View in PubMed

Recurrent somatic structural variations contribute to tumorigenesis in pediatric osteosarcoma Cell Rep. 2014 Apr 10; 7(1):104-12. . View in PubMed

Hypersensitivity reaction to high-dose methotrexate and successful rechallenge in a pediatric patient with osteosarcoma Pediatr Blood Cancer. 2014 Feb; 61(2):373-5. . View in PubMed

A Phase II multicenter, open-label, clinical and pharmokinetic trial of PM00104 in patients with advanced Ewing Family of Tumors Invest New Drugs. 2014 Feb; 32(1):171-7. . View in PubMed

Alternative formulations of sorafenib for use in children Pediatr Blood Cancer. 2013 Oct; 60(10):1642-6. . View in PubMed

Enhancement of the anti-melanoma response of Hu1418K322A by aCD40 + CpG. Cancer Immunol Immunother. 2013 Apr; 62(4):665-75. . View in PubMed

Lack of specificity of plasma concentrations of inhibin B and follicle-stimulating hormone for identification of azoospermic survivors of childhood cancer: a report from the St Jude lifetime cohort study J Clin Oncol. 2013 Apr 01; 31(10):1324-8. . View in PubMed

Phase I and clinical pharmacology study of bevacizumab, sorafenib, and low-dose cyclophosphamide in children and young adults with refractory/recurrent solid tumors Clin Cancer Res. 2013 Jan 01; 19(1):236-46. . View in PubMed

Timing of surgery and the role of adjuvant radiotherapy in ewing sarcoma of the chest wall: a single-institution experience Ann Surg Oncol. 2012 Nov; 19(12):3809-15. . View in PubMed

Analysis of prognostic factors in extraosseous Ewing sarcoma family of tumors: review of StJude Children's Research Hospital experience. Ann Surg Oncol. 2012 Nov; 19(12):3816-22. . View in PubMed

64Cu-p-NH2-Bn-DOTA-hu1418K322A, a PET radiotracer targeting neuroblastoma and melanoma. J Nucl Med. 2012 Nov; 53(11):1772-8. . View in PubMed

Clinical management of Ewing sarcoma of the bones of the hands and feet: a retrospective single-institution review J Pediatr Surg. 2012 Oct; 47(10):1806-10. . View in PubMed

Disseminated carcinoma ex pleomorphic adenoma in an adolescent confirmed by application of PLAG1 immunohistochemistry and FISH for PLAG1 rearrangement Head Neck Pathol. 2012 Sep; 6(3):377-83. . View in PubMed

Management of melanomas in children and young adults J Pediatr Hematol Oncol. 2012 May; 34 Suppl 2:S51-4. . View in PubMed

Dose escalation of intravenous irinotecan using oral cefpodoxime: a phase I study in pediatric patients with refractory solid tumors Pediatr Blood Cancer. 2012 Mar; 58(3):372-9. . View in PubMed

Jaw dysfunction related to pterygoid and masseter muscle dosimetry after radiation therapy in children and young adults with head-and-neck sarcomas Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):355-60. . View in PubMed

Genetic alterations in childhood melanoma Am Soc Clin Oncol Educ Book. 2012; 589-92. . View in PubMed

Safety and immunogenicity of live attenuated and inactivated influenza vaccines in children with cancer J Infect Dis. 2011 Nov 15; 204(10):1475-82. . View in PubMed

Quantitation of sorafenib and its active metabolite sorafenib N-oxide in human plasma by liquid chromatography-tandem mass spectrometry J Chromatogr B Analyt Technol Biomed Life Sci. 2010 Nov 01; 878(29):3033-8. . View in PubMed

Caveolin-1 modulates the ability of Ewing's sarcoma to metastasize Mol Cancer Res. 2010 Nov; 8(11):1489-500. . View in PubMed

Anti-GD2 antibody therapy for GD2-expressing tumors Curr Cancer Drug Targets. 2010 Mar; 10(2):200-9. . View in PubMed

Preliminary results from a prospective study using limited margin radiotherapy in pediatric and young adult patients with high-grade nonrhabdomyosarcoma soft-tissue sarcoma Int J Radiat Oncol Biol Phys. 2010 Mar 01; 76(3):874-8. . View in PubMed

Stability of cyclophosphamide in extemporaneous oral suspensions Ann Pharmacother. 2010 Feb; 44(2):295-301. . View in PubMed

Phase II trial of ixabepilone administered daily for five days in children and young adults with refractory solid tumors: a report from the children's oncology group Clin Cancer Res. 2010 Jan 15; 16(2):750-4. . View in PubMed

Body wall and visceral nonrhabdomyosarcoma soft tissue sarcomas in children and adolescents J Pediatr Surg. 2009 Oct; 44(10):1965-71. . View in PubMed

Tyrosine kinase inhibitor enhances the bioavailability of oral irinotecan in pediatric patients with refractory solid tumors J Clin Oncol. 2009 Sep 20; 27(27):4599-604. . View in PubMed

Sperm cryopreservation practices among adolescent cancer patients at risk for infertility Pediatr Hematol Oncol. 2009 Jun; 26(4):252-60. . View in PubMed

Immune therapies for neuroblastoma Cancer Biol Ther. 2009 May; 8(10):874-82. . View in PubMed

Combination of gemcitabine and docetaxel in the treatment of children and young adults with refractory bone sarcoma Cancer. 2008 Jul 15; 113(2):419-25. . View in PubMed

Stability of sunitinib in oral suspension Ann Pharmacother. 2008 Jul; 42(7):962-6. . View in PubMed

Pulmonary nodules discovered during the initial evaluation of pediatric patients with bone and soft-tissue sarcoma Pediatr Blood Cancer. 2008 Jun; 50(6):1147-53. . View in PubMed

Second cancers in patients with the Ewing sarcoma family of tumours Eur J Cancer. 2008 May; 44(7):983-91. . View in PubMed

Prognostic factors for local and distant control in Ewing sarcoma family of tumors Ann Oncol. 2008 Apr; 19(4):814-20. . View in PubMed

Desmoplastic small round cell tumor in childhood: the StJude Children's Research Hospital experience. Pediatr Blood Cancer. 2007 Sep; 49(3):274-9. . View in PubMed

Analysis of prognostic factors in ewing sarcoma family of tumors: review of StJude Children's Research Hospital studies. Cancer. 2007 Jul 15; 110(2):375-84. . View in PubMed

A model for quantitative changes in the magnetic resonance parameters of muscle in children after therapeutic irradiation Magn Reson Imaging. 2006 Dec; 24(10):1319-24. . View in PubMed

Pharmacologic inhibition of cyclin-dependent kinase 4/6 activity arrests proliferation in myoblasts and rhabdomyosarcoma-derived cells Mol Cancer Ther. 2006 May; 5(5):1299-308. . View in PubMed

Concomitant administration of vincristine, doxorubicin, cyclophosphamide, ifosfamide, and etoposide for high-risk sarcomas: the StJude Children's Research Hospital experience. Cancer. 2006 Apr 15; 106(8):1846-56. . View in PubMed

STAT3 is activated in a subset of the Ewing sarcoma family of tumours J Pathol. 2006 Apr; 208(5):624-32. . View in PubMed

The feasibility of adjuvant interferon alpha-2b in children with high-risk melanoma Cancer. 2005 Feb 15; 103(4):780-7. . View in PubMed

Low Dose Histone Deacetylase Inhibitor, Depsipeptide (FR901228), Promotes Adenoviral Transduction in Human Rhabdomyosarcoma Cell Lines Sarcoma. 2004; 8(1):25-30. . View in PubMed

Synergism between INK4a/ARF inactivation and aberrant HGF/SF signaling in rhabdomyosarcomagenesis Nat Med. 2002 Nov; 8(11):1276-80. . View in PubMed

Immunomagnetic purging of Ewing's sarcoma from blood and bone marrow: quantitation by real-time polymerase chain reaction J Clin Oncol. 2001 Aug 15; 19(16):3649-59. . View in PubMed

Autocrine Transforming Growth Factor-beta Growth Pathway in Murine Osteosarcoma Cell Lines Associated with Inability to Affect Phosphorylation of Retinoblastoma Protein Sarcoma. 2000; 4(3):93-102. . View in PubMed

Acute lymphoblastic leukemia with the (8;14)(q24;q32) translocation and FAB L3 morphology associated with a B-precursor immunophenotype: the Pediatric Oncology Group experience Leukemia. 1999 Jan; 13(1):135-41. . View in PubMed

AP-2 may contribute to IGF-II overexpression in rhabdomyosarcoma Oncogene. 1998 Sep 10; 17(10):1261-70. . View in PubMed

Albumin, IgG, retinol-binding protein, and alpha1-microglobulin excretion in childhood Pediatr Nephrol. 1998 May; 12(4):290-2. . View in PubMed

sc ctsi logoPowered by SC CTSI